More than 20% of sarcoidosis patients show signs of an immune system response against aluminum, beryllium, zirconium, and silica,…
David Melamed, PhD
David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by David Melamed, PhD
Sarcoidosis patients who more closely follow their established treatment plans were found to have a significantly improved health-related quality…
Sarcoidosis, and the medications prescribed to patients with the disease, do not lead to worse outcomes from COVID-19…
The Foundation for Sarcoidosis Research is partnering with the American Lung Association for its sixth annual effort…